No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Lexeo Therapeutics Inc Files for Mixed Shelf Offering of up to $300 Mln - SEC Filing
Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics
Baird Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $28
Lexeo Therapeutics' Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity
Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation
Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report